
Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Venture capital firm investing in medical device, biotechnology and healthcare technology companies

ShangBay Capital is a venture capital firm that gives its investors access to companies in medical devices, biotechnology and healthcare technology. It invests through venture equity participation.
The firm backs founders whose companies use novel ideas to meet serious clinical needs that remain unmet. Its leadership team says it has more than 100 years of combined experience and close links to strategic players.
Summary written by TrustList from the business's own published information, Oct 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Shangbay Capital.
Similar listings buyers compare against this one.

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Startup accelerator and early-stage investor running intensive batches for new technology founders

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications

A twelve-month commercialisation programme for researchers, universities and start-ups in Australia

A New York venture fund backing early technology founders, with a focus on health tech

A Dallas private equity firm investing in lower-middle market companies with growth potential
Everything here links back to the same verified catalogue. Pick your next stop.